Top Markets
Coin of the day
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
Classifica tra le azioni #24680
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
Prezzo delle azioni
$3.04
Capitalizzazione di mercato
$57.87M
Variazione (1 giorno)
-1.30%
Variazione (1 anno)
-73.45%
Paese
US
Scambia Elicio Therapeutics, Inc. (ELTX)

Categoria

Storico del prezzo dell'azione per Elicio Therapeutics, Inc. (ELTX)
Prezzo di chiusura più alto: $3.09 il 2026-08-01

Prezzo di chiusura più basso: $5.88 il 2023-11-01
Storico del prezzo dell'azione di Elicio Therapeutics, Inc. dal 2023 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 9.17%
2025 59.27%
2024 -21.55%
2023 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$547.71 37.80%
US
$1.04K 57.18%
NL
$145.75 455.87%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH